Maze Therapeutics, Inc. , a clinical stage biopharmaceutical company, develops small molecule precision medicines for the treatment of renal, cardiovascular, related metabolic diseases, and obesity in the United States.
Maze Therapeutics stock last closed at $8.79, up 4.89% from the previous day, and has decreased N/A in one year. It has underperformed other stocks in the Biotechnology industry by N/A percentage points. Maze Therapeutics stock is currently +31% from its 52-week low of $6.71, and -48.29% from its 52-week high of $17.00.
At the moment, there are 43.8M MAZE shares outstanding. The market cap of MAZE is $384.97M. In the last 24 hours, 329,814 MAZE shares were traded.
You need a brokerage account in order to access the NASDAQ market and buy MAZE stock.
Based on our analysis, eToro is the best stock brokerage. eToro gives you:
Get $10 towards your purchase of shares by creating an account with eToro now. This offer is only for US users.
Open eToro AccountNow that you've chosen the right brokerage, the next step is to fill out some personal info so you can invest in MAZE today.
Now that you have opened your account on our top ranked stock market app, you need to deposit funds:
Check out the tutorial below to see the process of depositing money into your new brokerage account.
Once you have selected the best place to buy Maze Therapeutics stock, it's absolutely critical to analyze their stock prior to buying, so you actually wrap your head around the risk and upside.
WallStreetZen was created to help average investors do more accurate fundamental analysis.
You can view all of the due diligence checks on MAZE's stock page.
Investors use a variety of different financial metrics, analyses, models, and charts to gauge MAZE's intrinsic value.
Using relative valuations ratios:
You can do additional valuation analysis on MAZE's stock here.
Out of 3 sell side analysts who track MAZE, the consensus analyst rating on MAZE is a Strong Buy
Please keep in mind that analyst ratings are not recommendations, nor are they investment advice.
You can dive deeper into what analysts are saying on the Maze Therapeutics stock forecast page.
In the last year, insiders at MAZE have not bought or sold any shares.
Learn more about who owns MAZE stock here.
No, Maze Therapeutics doesn't provide an income stream by paying out dividends.
One of the reasons eToro is our favorite brokerage is because of its social trading community.
Click below to see what other investors have to say.
You have two main order types:
Press the Open Trade button and your broker will execute the order.
If you need more help with buying stocks on eToro, watch the helpful video below:
Now that you own some MAZE stock, you'll want to keep up with your new investment.
Make a watchlist to see the latest developments about your MAZE stock.
To reiterate, here are the 6 steps for buying Maze Therapeutics stock:
If you need a brokerage account, eToro is our recommended option.
Get Started with eToro TodayIf you want to keep track of your new investment in Maze Therapeutics, hit the button below to create your watchlist.